Use of thyroid hormones in euthyroid patients with unexplained fatigue: analyses of aggregate data from European national surveys of professional endocrine society members.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bednarczuk Tomasz, Sugier Aleksandra, Attanasio Roberto, Nagy Endre V, Negro Roberto, Papini Enrico, Žarković Miloš, Akarsu Ersin, Alevizaki Maria, Ayvaz Göksun, Nedeljković Beleslin Biljana, Berta Eszter, Bodor Miklos, Borissova Anna M, Boyanov Mihail, Buffet Camille, Burlacu Maria-Cristina, Cohen Chagit A, Ćirić Jasmina, Díez Juan J, Dobnig Harald, Fadeyev Valentin, Field Benjamin C T, Fliers Eric, Führer-Sakel Dagmar, Frølich Jacob S, Galofré Juan C, Hakala Tommi, Jiskra Jan, Kopp Peter A, Krebs Michael, Kršek Michal, Kužma Martin, Lazúrová Ivica, Leenhardt Laurence, Ludgate Stephen, Luchytskiy Vitaliy, McGowan Anne, Melo Miguel, Metso Saara, Moran Carla, Morgunova Tatyana, Niculescu Dan A, Perić Božidar, Planck Tereza, Poiana Catalina, Puga Francisca M, Robenshtok Eyal, Rosselet Patrick, Ruchala Marek, Riis Kamilla R, Shepelkevich Alla, Tronko Mykola D, Unuane David, Vardarli Irfan, Visser W Edward, Vryonidou Andromachi, Younes Younes Ramazan, Yurenya Elena, Perros Petros, Hegedüs Laszlo
Аннотация
METHODS: We analyzed aggregate data from the THESIS (Treatment of Hypothyroidism in Europe by Specialists: an International Survey) online survey. We analyzed responses from 5,695 members of 28 national endocrine/thyroid societies' specialists to the statement: "Thyroid hormones may be indicated in biochemically euthyroid patients with unexplained fatigue".
RESULTS: Overall, 7.5% (426/5695) of respondents indicated that TH therapy might be considered for euthyroid patients with unexplained fatigue. The proportion of positive responses varied widely across different countries (between 1.1% in Switzerland and 29.3% in Serbia; p=2 ×10-16) and regions (between 4.7% in Western Europe and 8.7% in Western Asia or 8.8% in Eastern Europe; p=0.004). TH were more frequently prescribed for unexplained fatigue by male respondents (Odds Ratio, OR 1.45, 95% CI 1.18-1.78) and physicians practicing in private practice (OR 1.27, 95% CI 1.02-1.58), and less frequently by endocrinologists (OR 0.62, 95% CI 0.46-0.83).
CONCLUSION: A small, yet not negligible percentage of European thyroid-focused physicians consider using TH for euthyroid patients with unexplained fatigue, with significant variations based on geographic, demographic, and practice-related factors. Using levothyroxine and/or liothyronine in such cases lacks evidence and may partially contribute to the concerning overuse of TH therapy.